Results 121 to 130 of about 52,379 (265)

The association between obstructive sleep apnea syndrome and sarcopenia: a meta-analysis. [PDF]

Front Med (Lausanne)
Zhu Y, Luo Y, Du R, Dou X, Yang M, Huang W.   +5 more
europepmc   +1 more source

Clinical and Economic Burden of Obesity and Cardiovascular Disease Among Medicare Fee‐For‐Service Beneficiaries

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims This retrospective cohort study described clinical outcomes, healthcare resource utilisation (HCRU), and costs among Medicare beneficiaries with or without obesity and stratified by cardiovascular disease (CVD) risk. Materials and Methods Using Medicare FFS claims (Jan 2016–Dec 2022), beneficiaries were indexed after 12 months of ...
Jiayin Xue, Jeffrey Anderson, Ahong Huang, Ray Gou, Haiyan Sun, Junhui Zhao, Catherine Allende, Hannah Hua, Andriana Hohlbauch, Chanadda Chinthammit   +9 more
wiley   +1 more source

Prevalence of Obstructive Sleep Apnea Syndrome in Patients with Resistant Hypertension. [PDF]

J Clin Med
Ozyurt S, Taştan M, Gumus A, Beyazal Polat H, Ozcelik N.   +4 more
europepmc   +1 more source

Importance of Hypercortisolism in BP Control, Cardiovascular Risk and in Patients With Difficult‐to‐Control Hypertension: An Overview for Primary Care Physicians

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Hypertension remains one of the most prevalent and consequential modifiable cardiovascular risk factors worldwide, affecting approximately 1.28 billion adults globally and nearly half of the United States population. Despite the availability of effective therapies, optimal blood pressure control is achieved in fewer than one in four ...
Matthew A. Cavender
wiley   +1 more source

The Relationship Between Hepcidin and the Severity of Obstructive Sleep Apnea Syndrome and Obesity. [PDF]

Life (Basel)
Coban H, Ayan E, Colak M, Sarioglu N, Yilmaz Gunes G, Erel F, Yumrukuz Senel M, Yılmaz MA.   +7 more
europepmc   +1 more source

How Common Is Hypercortisolism in Patients With Hypertension? Risk Factors, Epidemiology, and Making a Diagnosis

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Endogenous hypercortisolism (EHC) is an underrecognised and clinically significant contributor to hypertension, particularly resistant hypertension. Once viewed as a rare entity, EHC is now understood as a spectrum of cortisol excess associated with adverse cardiometabolic outcomes and target‐organ damage.
Omar Al Dhaybi, Deepak L. Bhatt
wiley   +1 more source

Obstructive Sleep Apnea Syndrome and Ischemic Stroke: Investigating Inflammatory Mechanisms. [PDF]

Nat Sci Sleep
Zhang Z, Zhu Z, Chen Z, Liu X, Yu W, Aqdas T, Yuan R.   +6 more
europepmc   +1 more source

Tirzepatide Persistence and Associated Changes in Clinical Outcomes in US Adults With Obesity or Overweight: A 6‐Month Claims Database Analysis

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Tirzepatide is a once‐weekly glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) approved in the US for the treatment of Type 2 diabetes (T2D), weight loss and obstructive sleep apnoea. This study aimed to assess the utilisation and effectiveness of tirzepatide among individuals in a large ...
Theresa Hunter Gibble, Malvika Venkataraman, Donna Mojdami, Carlos Vallarino, Grace Stockbower, Michael Grabner, Mythili Ananth, Karishma Desai   +7 more
wiley   +1 more source

A sophisticated predictive framework for identifying obstructive sleep apnea syndrome in women with obesity during pregnancy. [PDF]

Eur J Obstet Gynecol Reprod Biol X
Jiang C, Zhou H, Yi J, Chen X.
europepmc   +1 more source

Real‐World Use of Semaglutide for Weight Management: Dose Titration, Discontinuation Patterns and Weight Changes

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim In December 2022, semaglutide injections for weight management were marketed in Denmark. Pre‐marketing trials documented high efficacy when adherence to the treatment and the recommended dose titration schedule was followed. This study aimed to describe real‐world use of semaglutide, including dose titration, discontinuation patterns and ...
Mie Dyberg Skandov, Katrine McLain Christensen, Dagmar Abelone Dalin, Janne Unkerskov, Andreas Brønden, Marie Lund, Mikkel Bring Christensen, Kristian Karstoft   +7 more
wiley   +1 more source